Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion
Emily Bodnar

Emily Bodnar Analyst Performance

Biotech Equity Research Analyst at HC Wainwright

Emily Bodnar is a stock analyst at HC Wainwright in the medical sector, covering 33 publicly traded companies. Over the past year, Emily Bodnar has issued 66 stock ratings, including strong buy, buy, and hold recommendations. While full access to Emily Bodnar's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Emily Bodnar's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
111 Last 1 Years
Buy Recommendations
90.09% 100 Buy Ratings
Companies Covered
33 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.9%1 ratings
Buy89.2%99 ratings
Hold9.9%11 ratings
Sell0.0%0 ratings

Out of 111 total stock ratings issued by Emily Bodnar at HC Wainwright, the majority (89.2%) have been Buy recommendations, followed by 9.9% Hold and 0.9% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
97.0% of companies on NASDAQ
32 companies
NYSE
3.0% of companies on NYSE
1 company

Emily Bodnar, an analyst at HC Wainwright, currently covers 33 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
33 companies
100.0%

Emily Bodnar of HC Wainwright specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
28 companies
84.8%
MED - DRUGS
3 companies
9.1%
BIOTECHNOLOGY
1 company
3.0%
MED INSTRUMENTS
1 company
3.0%

About Emily Bodnar

Emily Bodnar is a Vice President of Equity Research at H.C. Wainwright who joined the firm in January 2022. Ms. Bodnar’s research focuses on the Biotechnology and Women’s Healthcare industries. Prior to joining H.C. Wainwright, Ms. Bodnar was a Senior Equity Research Associate at Cantor Fitzgerald assisting in coverage of small/mid and large-cap biotechnology companies. Ms. Bodnar also worked as an Equity Research Associate at Berenberg Capital Markets assisting in coverage of small/mid-cap biotechnology companies. Ms. Bodnar graduated summa cum laude from Binghamton University where she received a Bachelor of Science. Ms. Bodnar has also taken several Biology and Immunology courses from Johns Hopkins University and Rice University.
Follow on LinkedIn

Emily Bodnar's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
5/18/2026Reiterated Rating$10.48$35.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
5/14/2026Boost Price Target$1.59$10.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
5/12/2026Boost Price Target$3.60$10.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
5/8/2026Boost Price Target$11.85$35.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
5/6/2026Boost Price Target$39.69$70.00Buy
TRAX
First Tracks Biotherapeutics
4/28/2026Initiated Coverage$18.10$30.00Buy
TRAX
First Tracks Biotherapeutics
4/28/2026Upgrade$20.05$30.00Strong-Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
4/20/2026Lower Price Target$27.11$50.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
4/1/2026Reiterated Rating$10.53$35.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/30/2026Reiterated Rating$57.40$66.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3/26/2026Boost Price Target$5.42$25.00Buy
Purple Biotech Ltd. Sponsored ADR stock logo
PPBT
Purple Biotech
3/13/2026Lower Price Target$4.10$30.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
3/10/2026Lower Price Target$3.84$7.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/9/2026Lower Price Target$17.25$38.00Buy
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
3/4/2026Lower Price Target$3.93$7.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
3/4/2026Boost Price Target$52.83$66.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
3/2/2026Reiterated Rating$20.36$32.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
2/26/2026Boost Price Target$13.11$49.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/23/2026Downgrade$113.84$115.00Neutral
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
2/17/2026Initiated Coverage$1.40$9.00Buy
Autolus Therapeutics PLC Sponsored ADR stock logo
AUTL
Autolus Therapeutics
2/17/2026Initiated Coverage$1.51$9.00Buy
NovoCure Limited stock logo
NVCR
NovoCure
2/12/2026Boost Price Target$10.50$47.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
2/12/2026Boost Price Target$28.71$65.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
2/4/2026Reiterated Rating$68.83$115.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
1/20/2026Downgrade$57.52$58.00Neutral
NovoCure Limited stock logo
NVCR
NovoCure
1/13/2026Lower Price Target$14.18$39.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/8/2026Downgrade$13.73$14.00Neutral
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
12/24/2025Boost Price Target$28.85$62.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
12/19/2025Reiterated Rating$34.72$47.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
12/12/2025Boost Price Target$22.39$32.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
12/11/2025Boost Price Target$30.68$45.00Buy
Acrivon Therapeutics, Inc. stock logo
ACRV
Acrivon Therapeutics
11/25/2025Reiterated Rating$2.36$19.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/24/2025Lower Price Target$39.61$51.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
11/20/2025Lower Price Target$22.34$48.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
11/18/2025Boost Price Target$19.85$36.00Buy
Artiva Biotherapeutics, Inc. stock logo
ARTV
Artiva Biotherapeutics
11/12/2025Boost Price Target$3.65$15.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/11/2025Lower Price Target$33.98$52.00Buy
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
11/7/2025Lower Price Target$4.05$9.00Buy
Context Therapeutics Inc. stock logo
CNTX
Context Therapeutics
11/6/2025Boost Price Target$1.13$5.00Buy
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
11/5/2025Upgrade$8.09$18.00Buy
I’m sounding the alarm (Ad)

Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.tc pixel

Watch Stansberry's full investigation and see which companies to buy and sell
NovoCure Limited stock logo
NVCR
NovoCure
10/30/2025Boost Price Target$12.79$42.00Buy
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
10/29/2025Boost Price Target$19.89$28.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/27/2025Boost Price Target$30.11$72.00Buy
Agenus Inc. stock logo
AGEN
Agenus
10/20/2025Reiterated Rating$3.88Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
10/20/2025Reiterated Rating$9.36$28.00Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
10/14/2025Initiated Coverage$1.68$12.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
10/6/2025Initiated Coverage$36.71$60.00Buy
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
10/6/2025Initiated Coverage$36.76$60.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
9/30/2025Boost Price Target$23.27$59.00Buy
IO Biotech, Inc. stock logo
IOBT
IO Biotech
9/29/2025Downgrade$0.35Neutral
Agenus Inc. stock logo
AGEN
Agenus
9/10/2025Reiterated Rating$5.07$23.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
9/4/2025Reiterated Rating$35.90$56.00Buy
Agenus Inc. stock logo
AGEN
Agenus
8/28/2025Reiterated Rating$4.54$23.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
8/15/2025Upgrade$15.32$35.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
8/13/2025Reiterated Rating$14.50$36.00Buy
Femasys Inc. stock logo
FEMY
Femasys
8/11/2025Lower Price Target$0.85$8.00Buy
Context Therapeutics Inc. stock logo
CNTX
Context Therapeutics
8/7/2025Lower Price Target$0.70$4.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
7/22/2025Lower Price Target$2.70$9.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
7/15/2025Downgrade$29.53$35.00Neutral
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
7/7/2025Lower Price Target$3.04$20.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
7/1/2025Reiterated Rating$5.52$36.00Buy
Femasys Inc. stock logo
FEMY
Femasys
6/25/2025Reiterated Rating$0.95$12.00Buy
Arcellx, Inc. stock logo
ACLX
Arcellx
6/16/2025Reiterated Rating$66.00$115.00Buy
Femasys Inc. stock logo
FEMY
Femasys
6/11/2025Reiterated Rating$0.84$12.00Buy
Agenus Inc. stock logo
AGEN
Agenus
6/4/2025Upgrade$5.00$25.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
5/14/2025Initiated Coverage$1.80$10.00Buy
Agenus Inc. stock logo
AGEN
Agenus
5/13/2025Reiterated Rating$3.50Neutral
Femasys Inc. stock logo
FEMY
Femasys
5/9/2025Lower Price Target$1.16$12.00Buy
Agenus Inc. stock logo
AGEN
Agenus
4/30/2025Reiterated Rating$3.05Neutral
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
4/28/2025Reiterated Rating$4.91$30.00Buy
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
4/24/2025Reiterated Rating$1.71$11.00Buy
Briacell Therap stock logo
BCTX
Briacell Therap
4/22/2025Reiterated Rating$48.03$320.00Buy
TransCode Therapeutics Inc. stock logo
RNAZ
TransCode Therapeutics
4/16/2025Lower Price Target$11.14$280.00Buy
vTv Therapeutics Inc. stock logo
VTVT
vTv Therapeutics
4/9/2025Initiated Coverage$15.80$36.00Buy
IO Biotech, Inc. stock logo
IOBT
IO Biotech
4/1/2025Reiterated Rating$1.09$12.00Buy
Genelux Corporation stock logo
GNLX
Genelux
3/31/2025Reiterated Rating$3.08$30.00Buy
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
3/31/2025Reiterated Rating$0.68$8.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/28/2025Reiterated Rating$1.34$15.00Buy
Nkarta, Inc. stock logo
NKTX
Nkarta
3/27/2025Reiterated Rating$1.37$18.00Buy
Imunon, Inc. stock logo
IMNN
Imunon
3/26/2025Reiterated Rating$15.00$210.00Buy
Acrivon Therapeutics, Inc. stock logo
ACRV
Acrivon Therapeutics
3/26/2025Lower Price Target$5.39$19.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3/26/2025Reiterated Rating$10.86$105.00Buy
Genelux Corporation stock logo
GNLX
Genelux
3/25/2025Reiterated Rating$3.41$30.00Buy
Context Therapeutics Inc. stock logo
CNTX
Context Therapeutics
3/21/2025Reiterated Rating$0.77$5.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/19/2025Reiterated Rating$4.14$30.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/19/2025Boost Price Target$1.60$15.00Buy
Agenus Inc. stock logo
AGEN
Agenus
3/18/2025Reiterated Rating$1.78Neutral
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
3/18/2025Reiterated Rating$2.77$11.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
3/18/2025Reiterated Rating$8.06$35.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
3/17/2025Reiterated Rating$8.45$36.00Buy
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
TransCode Therapeutics Inc. stock logo
RNAZ
TransCode Therapeutics
3/13/2025Reiterated Rating$25.34$560.00Buy
Femasys Inc. stock logo
FEMY
Femasys
3/13/2025Reiterated Rating$1.44$12.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3/12/2025Reiterated Rating$11.11$105.00Buy
Agenus Inc. stock logo
AGEN
Agenus
3/12/2025Reiterated Rating$2.05Neutral
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/11/2025Reiterated Rating$4.25$30.00Buy
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
3/11/2025Reiterated Rating$5.14$40.00Buy
NextCure, Inc. stock logo
NXTC
NextCure
3/7/2025Reiterated Rating$8.55$36.00Buy
IO Biotech, Inc. stock logo
IOBT
IO Biotech
3/5/2025Reiterated Rating$0.91$12.00Buy
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
3/5/2025Reiterated Rating$4.18$30.00Buy
Femasys Inc. stock logo
FEMY
Femasys
2/26/2025Reiterated Rating$1.58$12.00Buy
MiNK Therapeutics, Inc. stock logo
INKT
MiNK Therapeutics
2/25/2025Boost Price Target$10.65$35.00Buy
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
2/24/2025Initiated Coverage$35.22$58.00Buy
Femasys Inc. stock logo
FEMY
Femasys
2/11/2025Reiterated Rating$1.26$12.00Buy
TransCode Therapeutics Inc. stock logo
RNAZ
TransCode Therapeutics
2/6/2025Reiterated Rating$321.02$560.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
2/3/2025Reiterated Rating$1.05$18.00Buy
Briacell Therap stock logo
BCTX
Briacell Therap
2/3/2025Boost Price Target$50.80$320.00Buy
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
1/30/2025Reiterated Rating$12.84$105.00Buy
Agenus Inc. stock logo
AGEN
Agenus
1/22/2025Reiterated Rating$3.83Neutral
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
1/14/2025Reiterated Rating$1.95Neutral
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
1/10/2025Lower Price Target$6.99$40.00Buy